🟢 Pyxis Oncology is trading 6.54% up today amid H.C. Wainwright conference anticipation

Pyxis Oncology is trading 6.54% up at $3.42, with H.C. Wainwright conference anticipation the most plausible support, though the immediate catalyst remains uncertain.

• Scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, at 9:30 a.m. EDT.
• Recent positive MICVO clinical data and H.C. Wainwright’s September 10 price-target increase may support sentiment.
• The broader market is weaker; no new company announcement clearly explains the move.